about
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology...
Read More
114.79
0.07
(0.06%)
96,519.6
XNAS Volume
XNAS 07 Apr, 2026 9:48 AM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Arcellx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..